Semaglutide vs Retatrutide: the honest comparison
Retatrutide produces roughly 1.5× the fat loss of Semaglutide on paper, but Semaglutide has a 5+ year clinical track record and Retatrutide is still research-stage. Jumping straight from nothing to Retatrutide is not the right sequence — start with Semaglutide and only move on if you plateau.
Side-by-side facts
| Semaglutide | Retatrutide | |
|---|---|---|
| Class | GLP-1 receptor agonist | Triple GIP / GLP-1 / glucagon receptor agonist |
| Half-life | Approximately 7 days (once-weekly dosing) | Approximately 6 days (once-weekly dosing) |
| Typical dose | Titration: 0.25 mg (250 mcg) → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg weekly | Titration: 2 mg → 4 mg → 8 mg → 12 mg weekly (trial protocols) |
| Category | GLP-1 / metabolic | GLP-1/GIP/glucagon / metabolic |
| FDA status | FDA approved as Ozempic (type 2 diabetes), Wegovy (obesity), Rybelsus (oral T2D). Compounded semaglutide is not FDA approved and is under active FDA scrutiny. | Investigational. Eli Lilly Phase 3 trials ongoing as of 2026. Not FDA approved. |
| Storage | Lyophilized stable refrigerated. | Lyophilized refrigerated. |
What they have in common
Both are once-weekly injectable appetite-suppressing peptides aimed at fat loss and metabolic control. Both slow gastric emptying and reduce caloric intake.
When to pick Semaglutide
Pick Semaglutide first. It is FDA approved, widely prescribed, has the deepest real-world safety dataset, and for most people will produce meaningful, sustainable fat loss. The right starting compound for almost any GLP-1-naive user.
When to pick Retatrutide
Pick Retatrutide only when Semaglutide has plateaued short of the target, you have ruled out Tirzepatide as an intermediate step, and you have access to a reliable research source. Deeper weight loss; more nausea during titration; less long-term safety data.
Can you stack them?
No. Two incretin agonists run together is GI-side-effect amplification with no unique benefit.
The two compounds
Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. It slows gastric emptying…
Retatrutide
Retatrutide is an investigational triple agonist at GIP, GLP-1, and glucagon receptors. Phase 2 trial data reported weight loss exceeding…
Track either compound on iPhone
Peptide Protocol schedules doses, calculates reconstitution, and logs side effects for both — on iPhone, free to download.
See the app →Frequently asked questions
What is the main difference between Semaglutide and Retatrutide?
Retatrutide hits three receptors (GLP-1, GIP, glucagon) to Semaglutide's one. That is a generational jump in mechanism, which matches the generational jump in trial weight-loss figures.
Can you stack Semaglutide and Retatrutide?
No. Two incretin agonists run together is GI-side-effect amplification with no unique benefit.
Which is better, Semaglutide or Retatrutide?
Retatrutide produces roughly 1.5× the fat loss of Semaglutide on paper, but Semaglutide has a 5+ year clinical track record and Retatrutide is still research-stage. Jumping straight from nothing to Retatrutide is not the right sequence — start with Semaglutide and only move on if you plateau.
When should I pick Semaglutide?
Pick Semaglutide first. It is FDA approved, widely prescribed, has the deepest real-world safety dataset, and for most people will produce meaningful, sustainable fat loss. The right starting compound for almost any GLP-1-naive user.
When should I pick Retatrutide?
Pick Retatrutide only when Semaglutide has plateaued short of the target, you have ruled out Tirzepatide as an intermediate step, and you have access to a reliable research source. Deeper weight loss; more nausea during titration; less long-term safety data.
Are Semaglutide and Retatrutide FDA approved?
Semaglutide: FDA approved as Ozempic (type 2 diabetes), Wegovy (obesity), Rybelsus (oral T2D). Compounded semaglutide is not FDA approved and is under active FDA scrutiny. — Retatrutide: Investigational. Eli Lilly Phase 3 trials ongoing as of 2026. Not FDA approved.
Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.